- Home
- AGIO vs FVRR Comparison
AGIO vs FVRR Comparison
Compare AGIO & FVRR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGIO
- FVRR
- Stock Information
- Founded
- AGIO 2007
- FVRR 2010
- Country
- AGIO United States
- FVRR Israel
- Employees
- AGIO N/A
- FVRR N/A
- Industry
- AGIO Biotechnology: Pharmaceutical Preparations
- FVRR Business Services
- Sector
- AGIO Health Care
- FVRR Consumer Discretionary
- Exchange
- AGIO Nasdaq
- FVRR Nasdaq
- Market Cap
- AGIO 1.4B
- FVRR 1.0B
- IPO Year
- AGIO 2013
- FVRR 2019
- Fundamental
- Price
- AGIO $33.97
- FVRR $30.02
- Analyst Decision
- AGIO Buy
- FVRR Buy
- Analyst Count
- AGIO 6
- FVRR 12
- Target Price
- AGIO $58.60
- FVRR $35.00
- AVG Volume (30 Days)
- AGIO 529.1K
- FVRR 473.5K
- Earning Date
- AGIO 07-31-2025
- FVRR 07-30-2025
- Dividend Yield
- AGIO N/A
- FVRR N/A
- EPS Growth
- AGIO N/A
- FVRR 127.71
- EPS
- AGIO 11.45
- FVRR 0.49
- Revenue
- AGIO $37,035,000.00
- FVRR $405,141,000.00
- Revenue This Year
- AGIO $22.30
- FVRR $13.12
- Revenue Next Year
- AGIO $219.19
- FVRR $8.65
- P/E Ratio
- AGIO $3.00
- FVRR $60.32
- Revenue Growth
- AGIO 25.96
- FVRR 10.41
- 52 Week Low
- AGIO $23.42
- FVRR $20.78
- 52 Week High
- AGIO $62.58
- FVRR $36.11
- Technical
- Relative Strength Index (RSI)
- AGIO 52.40
- FVRR 45.04
- Support Level
- AGIO $32.53
- FVRR $28.63
- Resistance Level
- AGIO $34.34
- FVRR $29.74
- Average True Range (ATR)
- AGIO 1.28
- FVRR 0.87
- MACD
- AGIO -0.31
- FVRR -0.21
- Stochastic Oscillator
- AGIO 20.98
- FVRR 25.28
About AGIO Agios Pharmaceuticals Inc.
Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236, and others.
About FVRR Fiverr International Ltd. no par value
Fiverr International Ltd is involved in buying and selling digital services in the same fashion as physical goods on an e-commerce platform. It is set out to design a digital marketplace that is built with a comprehensive SKU-like services catalog and a search, finds, and order process that mirrors a typical e-commerce transaction. The service offerings of the company include Graphics and Design, Digital Marketing, Wiring and Translation, and Video and Animation among others.